Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 1
2020 4
2021 8
2022 6
2023 12
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Results by year

Filters applied: . Clear all
Page 1
Effectiveness, safety and cost analysis of dalbavancin in clinical practice.
Arrieta-Loitegui M, Caro-Teller JM, Ortiz-Pérez S, López-Medrano F, San Juan-Garrido R, Ferrari-Piquero JM. Arrieta-Loitegui M, et al. Among authors: caro teller jm. Eur J Hosp Pharm. 2022 Jan;29(1):55-58. doi: 10.1136/ejhpharm-2020-002315. Epub 2020 Oct 5. Eur J Hosp Pharm. 2022. PMID: 33020060 Free PMC article.
Effectiveness of ceftazidime-avibactam for the treatment of infections due to Pseudomonas aeruginosa.
Corbella L, Boán J, San-Juan R, Fernández-Ruiz M, Carretero O, Lora D, Hernández-Jiménez P, Ruiz-Ruigómez M, Rodríguez-Goncer I, Silva JT, López-Medrano F, Lizasoain M, Villa J, Caro-Teller JM, Aguado JM. Corbella L, et al. Among authors: caro teller jm. Int J Antimicrob Agents. 2022 Feb;59(2):106517. doi: 10.1016/j.ijantimicag.2021.106517. Epub 2022 Jan 3. Int J Antimicrob Agents. 2022. PMID: 34990760
Antibiotic Prescribing in Children Hospitalized With COVID-19 and Multisystem Inflammatory Syndrome in Spain: Prevalence, Trends, and Associated Factors.
Aguilera-Alonso D, Epalza C, Sanz-Santaeufemia FJ, Grasa C, Villanueva-Medina S, Melendo Pérez S, Cervantes Hernández E, Urretavizcaya-Martínez M, Pino R, Gómez MN, Orive JP, González Zárate A, Vidal Lana P, González Montero R, Ruiz González S, Calvo C, Iglesias-Bouzas MI, Caro-Teller JM, Domínguez-Rodríguez S, Ballesteros Á, Mesa J, Cobos-Carrascosa E, Tagarro A, Moraleda C. Aguilera-Alonso D, et al. Among authors: caro teller jm. J Pediatric Infect Dis Soc. 2022 May 30;11(5):225-228. doi: 10.1093/jpids/piac003. J Pediatric Infect Dis Soc. 2022. PMID: 35188190 Free PMC article.
Analysis of the factors predicting clinical response to tocilizumab therapy in patients with severe COVID-19.
San-Juan R, Fernández-Ruiz M, López-Medrano F, Carretero O, Lalueza A, Maestro de la Calle G, Pérez-Jacoiste Asín MA, Bueno H, Caro-Teller JM, Catalán M, de la Calle C, García-García R, Gómez C, Laguna-Goya R, Lizasoáin M, Martínez-López J, Origüen J, Sevillano Á, Gutiérrez E, de Miguel B, Aguilar F, Parra P, Ripoll M, Ruiz-Merlo T, Trujillo H, Pablos JL, Paz-Artal E, Lumbreras C, Aguado JM; H12O Immunomodulation Therapy for COVID-19 Group, the Spanish Network for Research in Infectious Diseases (REIPI). San-Juan R, et al. Among authors: caro teller jm. Int J Infect Dis. 2022 Apr;117:56-64. doi: 10.1016/j.ijid.2022.01.040. Epub 2022 Jan 23. Int J Infect Dis. 2022. PMID: 35081417 Free PMC article.
Tocilizumab for the treatment of adult patients with severe COVID-19 pneumonia: A single-center cohort study.
Fernández-Ruiz M, López-Medrano F, Pérez-Jacoiste Asín MA, Maestro de la Calle G, Bueno H, Caro-Teller JM, Catalán M, de la Calle C, García-García R, Gómez C, Laguna-Goya R, Lizasoáin M, Martínez-López J, Origüen J, Pablos JL, Ripoll M, San Juan R, Trujillo H, Lumbreras C, Aguado JM. Fernández-Ruiz M, et al. Among authors: caro teller jm. J Med Virol. 2021 Feb;93(2):831-842. doi: 10.1002/jmv.26308. Epub 2020 Jul 27. J Med Virol. 2021. PMID: 32672860 Free PMC article.
Effectiveness of anakinra for tocilizumab-refractory severe COVID-19: A single-centre retrospective comparative study.
de la Calle C, López-Medrano F, Pablos JL, Lora-Tamayo J, Maestro-de la Calle G, Sánchez-Fernández M, Fernández-Ruiz M, Pérez-Jacoiste Asín MA, Caro-Teller JM, García-García R, Catalán M, Martínez-López J, Sevillano Á, Origüen J, Ripoll M, San Juan R, Lalueza A, de Miguel B, Carretero O, Aguilar F, Gómez C, Paz-Artal E, Bueno H, Lumbreras C, Aguado JM. de la Calle C, et al. Among authors: caro teller jm. Int J Infect Dis. 2021 Apr;105:319-325. doi: 10.1016/j.ijid.2021.02.041. Epub 2021 Feb 13. Int J Infect Dis. 2021. PMID: 33592340 Free PMC article.
Safety of tocilizumab in COVID-19 pregnant women and their newborn: A retrospective study.
Jiménez-Lozano I, Caro-Teller JM, Fernández-Hidalgo N, Miarons M, Frick MA, Batllori Badia E, Serrano B, Parramon-Teixidó CJ, Camba-Longueira F, Moral-Pumarega MT, San Juan-Garrido R, Cabañas Poy MJ, Suy A, Gorgas Torner MQ. Jiménez-Lozano I, et al. Among authors: caro teller jm. J Clin Pharm Ther. 2021 Aug;46(4):1062-1070. doi: 10.1111/jcpt.13394. Epub 2021 Feb 26. J Clin Pharm Ther. 2021. PMID: 33638257 Free PMC article.
27 results